|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Accuretic
Mylan Launches Generic Accupril - Feb 28, 2007 Forbes,Mylan Laboratories Inc. said Wednesday its Mylan Pharmaceuticals Inc. subsidiary launched generic versions of Pfizer's Accupril and Accuretic blood-pressure
Mylan markets generic versions of Pfizer drugs - Feb 28, 2007 Bizjournals.com,Quinapril tablets and Quinapril HCl and HCTZ tablets are the generic versions of Pfizer's Accupril and Accuretic tablets, respectively,
Business news briefs - Feb 28, 2007 Pittsburgh Post Gazette,Mylan Laboratories said it has begun to market quinapril tablets, the generic versions of Pfizer Inc.'s Accupril and Accuretic tablets.
Pfizer to Transform In Rapidly Changing Healthcare Environment Oct 19, 2006 The loss of US exclusivity on a number of our major medicines since 2004 (Accupril/Accuretic, Diflucan, Neurontin, Zithromax, and Zoloft), as well as the ... -MSN Money
Market Report -- Story Stocks (PFE) Oct 19, 2006 The patent expiration of many of Pfizer's top-selling products, including Accupril/Accuretic, Diflucan, Neurontin, Zithromax, Zoloft, and Bextra, have had a ... -MSN Money
Pfizer Delivers Strong Second-Quarter 2006 Results, Driven By ... Jul 20, 2006 2006 worldwide revenues (excluding the impact of foreign exchange) of products that have lost US exclusivity in 2004-06: Accupril/Accuretic, Diflucan, Neurontin ... -PR Newswire
Advisory - Health Canada reminds women not to use ACE inhibitors ... Jun 29, 2006 ...name Vasotec IV) Drugs containing ACE inhibitors include: - Quinapril HCI - Hydrochlorothiazide (sold under the brand name Accuretic) - Perindopril Erbumine ... -CNW Telbec (Communiqués de presse)
Pfizer First-Quarter 2006 Financial Results Reflect Operating and ... Apr 19, 2006 ...worldwide revenues (excluding the impact of foreign exchange) of products that have lost US exclusivity in 2004-06 -- Accupril/Accuretic, Diflucan, Neurontin ... - International News Service
Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ... Jan 19, 2006 ...$13,101 (11) $44,284 $46,133 (4) Celebrex 472 1,008 (53) 1,730 3,302 (48) Bextra (2) 417 * (61) 1,286 * Dynastat 8 14 (44) 34 46 (25) Accupril/Accuretic 44 165 ... - PR Newswire
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|